Home' Australasian BioTechnology : Vol 27 No 1 Contents Australasian BioTechnology | Volume 27 | Number 1 29
at AusBiotech's AusMedtech 2017 & ICMMB 2017
as well as the efficiency and transparency of its
legal system. Likewise, Australia's legislative and
regulatory frameworks are very similar to those
of other developed Western countries, providing
investors with certainty and stability.
Australia has been ranked the fifth most economically
free country in the world by The Wall Street Journal,
which, combined with Australia's 25 years of
continuous economic growth and AAA credit rating
from all three major agencies, makes Australia the
ideal location for business investment.
Once companies have settled on taking advantage
of Australia's many benefits, they are increasingly
choosing Adelaide as their preferred location.
Adelaide is the most cost-effective major city in
Australia. Office and industrial land is substantially
cheaper than it is in cities such as Sydney and
Melbourne, and salaries are lower on average because
of the cheaper cost of living.
Adelaide is dedicated to the life sciences, investing
$3.6 billion in Adelaide BioMed City, one of the
largest health and life sciences clusters in the Southern
Hemisphere that brings together institutions from
research, education and clinical care, right through to
business development and incubation.
Adelaide also has committed infrastructure for the
entire medical devices value chain. The city's three
universities have a strong emphasis on life sciences
research. Flinders University features the Medical
Device Research Institute, which focuses on research
and translation to patient. It's located at Tonsley
Innovation District, which also provides space for
high-tech manufacturing companies, including an
increasing number that are building medical devices,
forming a cluster of like-minded, innovative firms.
Tonsley's inventive pod-based solution to housing
companies allows manufacturers to grow without
A good example is Micro-X, a manufacturer of mobile
X-ray machines. This company chose Adelaide so
that it could use the city's traditional expertise in
automotive and defence manufacturing. In particular,
Micro-X employed several local former General Motors
(GM) employees, who brought world's best practice
manufacturing techniques with them.
Adelaide's automotive experience includes GM
and Mitsubishi car manufacturing, while defence
experience includes ship and submarine building.
developed a culture
that delivers precision
with a strikingly low
defect rate and high
traceability. Six Sigma,
Lean manufacturing and
Kaizen techniques have helped
to deliver this for car companies around the world,
and these techniques are now being applied to
medical devices manufacturing in Adelaide.
As healthcare costs increase, and both public health
systems and insurance companies struggle to cope,
the businesses that will thrive will be those that can
deliver better products more cheaply.
Micro-X is also using Adelaide's supply chain to
deliver high-quality parts from manufacturers across
the automotive, defence and aerospace industries.
This strong tradition of manufacturing provides
Adelaide with a supply chain that is able to deliver
precision mechanics, optoelectronics, sensors,
nanomaterials, composites, firmware, artificial
intelligence and data analytics. These suppliers are
increasingly acquiring ISO 13485 certification as they
move into medical-device part fabrication.
Adelaide also has a business-friendly environment,
which companies appreciate. The government has
established Health Industries South Australia, an
agency that provides life sciences companies with a
single point of contact. Staffed by a team of business
professionals, we provide advice on regulations and
government grants, and help with access to land.
We are well connected to government decision-
makers, local industry, and the research and financial
communities. Importantly, we are with you every step
of the way when you invest in Adelaide.
Companies in Adelaide are being offered a great
opportunity -- taking advantage of huge markets in the
Asia-Pacific region, global best practice manufacturing
techniques, and an innovative and growing life
sciences community, all supported by a government
with a clear vision for economic
development, providing practical
support for medtech companies.
Marco Baccanti will be speaking at
AusMedtech 2017 & ICMMB 2017
Links Archive Vol 26 No 3 Vol 27 No 2 Navigation Previous Page Next Page